articleThe LancetSep 19, 2009GREEN OA

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

AJAndrés JM FerreriMRMichele ReniMFMarco FoppoliMMMaurizio MartelliGAGerasimus A Pangalis

San Raffaele University of Rome · Sapienza University of Rome · +20 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

662
total citations
FWCI
21.16
Percentile
100%
References
36
Citations per year

Authors

32

Topics & keywords

Topics
Keywords
  • Methotrexate
  • Cytarabine
  • Medicine
  • Antimetabolite
  • Chemotherapy
  • Internal medicine
  • Gastroenterology
  • Clinical endpoint
No related works found for this paper.